Table 2 Methylation data and analysis
Gene | Samples | % samples MtI>0 a | % samples MtI>5% b | Kruskall–Wallis test of mean rank (diff. T/N) | Reference MtI c | % tumours ⩾ Reference MtI |
|---|---|---|---|---|---|---|
P16 | T | 45% (36/80) | 28% (22/80) | P=0.048 | 0.046 | 22/80 28% |
N | 27% (7/26) | 4% (1/26) | ||||
RARβ | T | 85% (68/80) | 73% (58/80) | P=0.088 (NS) | 0.215 | 15/80 19% |
N | 71% (15/21) | 62% (13/21) | ||||
CYGB | T | 74% (59/80) | 65% (52/80) | P=0.002 | 0.149 | 35/80 44% |
N | 57% (12/21) | 52% (11/21) | ||||
CYCA1 | T | 72% (56/78) | 53% (42/78) | P=0.001 | 0.002 | 38/78 49% |
N | 11% (1/9) | 0% (0/9) | ||||
ECAD | T | 83% (59/71) | 42% (30/71) | P=0.347 (NS) | 0.218 | 1/71 1% |
N | 56% (10/18) | 33% (6/18) |
